Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 210,000,577 papers from all fields of science
Search
Sign In
Create Free Account
GO 201
Known as:
GO-201
, GO201 cpd
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Broader (1)
Peptides
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
MUC1 intracellular bioactivation mediates lung fibrosis
J. Milara
,
Beatriz Ballester
,
+6 authors
J. Cortijo
Thorax
2019
Corpus ID: 208645473
Background Serum KL6/mucin 1 (MUC1) has been identified as a potential biomarker in idiopathic pulmonary fibrosis (IPF), but the…
Expand
2018
2018
Inhibition of MUC1-C entering nuclear suppresses MYC expression and attenuates malignant growth in esophageal squamous cell carcinoma
Zhongwei Xin
,
Gongsun Xin
,
+4 authors
Xiangyan Liu
OncoTargets and Therapy
2018
Corpus ID: 50784739
Background The mucin 1 (MUC1) heterodimeric protein (N-terminal subunit and C-terminal subunit) is aberrantly overexpressed in…
Expand
2017
2017
Muc1 knockout potentiates murine lung carcinogenesis involving an epiregulin-mediated EGFR activation feedback loop
Xiuling Xu
,
Wenshu Chen
,
+8 authors
Y. Lin
Carcinogenesis
2017
Corpus ID: 4465127
Mucin 1 (MUC1) is a tumor antigen that is aberrantly overexpressed in various cancers, including lung cancer. Our previous in…
Expand
2016
2016
Cigarette Smoke Mediates Nuclear to Cytoplasmic Trafficking of Transcriptional Inhibitor Kaiso through MUC1 and P120-Catenin.
Li-li Zhang
,
M. Gallup
,
L. Zlock
,
Yu Ting Feeling Chen
,
W. Finkbeiner
,
N. McNamara
American Journal of Pathology
2016
Corpus ID: 205386513
2013
2013
Disrupting BCR-ABL in combination with secondary leukemia-specific pathways in CML cells leads to enhanced apoptosis and decreased proliferation.
David W. Woessner
,
Carol S. Lim
Molecular Pharmaceutics
2013
Corpus ID: 207725397
Chronic myeloid leukemia (CML) is a myeloproliferative disorder caused by expression of the fusion gene BCR-ABL following a…
Expand
2012
2012
MUC1c Regulates Cell Survival in Pancreatic Cancer by Preventing Lysosomal Permeabilization
Sulagna Banerjee
,
Nameeta R Mujumdar
,
+5 authors
A. Saluja
PLoS ONE
2012
Corpus ID: 14305723
Background MUC1 is a type I transmembrane glycoprotein aberrantly overexpressed in various cancer cells including pancreatic…
Expand
Highly Cited
2011
Highly Cited
2011
MUC1-C Oncoprotein Promotes STAT3 Activation in an Autoinductive Regulatory Loop
R. Ahmad
,
H. Rajabi
,
+6 authors
D. Kufe
Science Signaling
2011
Corpus ID: 4966350
An inflammatory response of epithelial cells may be co-opted to promote cancer cell survival. Caught in a Loop Mucin 1 (MUC1), a…
Expand
2010
2010
Terminal differentiation of chronic myelogenous leukemia cells is induced by targeting of the MUC1-C oncoprotein
L. Yin
,
R. Ahmad
,
+5 authors
D. Kufe
Cancer Biology & Therapy
2010
Corpus ID: 4962293
Chronic myelogenous leukemia (CML) is caused by expression of the Bcr-Abl fusion protein in hematopoietic stem cells. The MUC1-C…
Expand
Highly Cited
2009
Highly Cited
2009
Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells.
D. Raina
,
R. Ahmad
,
+7 authors
D. Kufe
Cancer Research
2009
Corpus ID: 4968438
The mucin 1 (MUC1) oncoprotein is aberrantly overexpressed by approximately 90% of human breast cancers. However, there are no…
Expand
Highly Cited
2009
Highly Cited
2009
MUC1 oncoprotein is a druggable target in human prostate cancer cells
M. D. Joshi
,
R. Ahmad
,
+5 authors
D. Kufe
Molecular Cancer Therapeutics
2009
Corpus ID: 4960318
Human prostate cancers are dependent on the androgen receptor for their progression. The MUC1 heterodimeric oncoprotein is…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE